Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... anticoagulant therapy in patients with the nonvalvular AF and CKD are considered in the review. The possibility ..."
 
Vol 14, No 6 (2018) Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva, O. N. Tkacheva
"... The review focuses on the use of oral anticoagulants in fragile elderly patients. The issues ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... This article affects  the problems of using NOAC in the most defenseless groups  of patients ..."
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... The safety of anticoagulant therapy is discussed. Warfarin position in prevention of thrombotic ..."
 
Vol 12, No 4 (2016) The use of oral anticoagulants in patients with atrial fibrillation: cohort study data Abstract  similar documents
O. V. Gaisenok, A. S. Leonov
"... Aim. To study the rate of prescription of oral anticoagulants (OAC) in patients with atrial ..."
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... Prevention of thromboembolic complications in patients with atrial fibrillation during catheter ..."
 
Vol 15, No 3 (2019) Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation Abstract  similar documents
L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin
"... of canceling oral anticoagulants in 107 (50.0%) patients. Conclusion. A significantly higher frequency ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties ..."
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... % of the patients received appropriate anticoagulant therapy. Warfarin was prescribed in 73% of the cases, of them ..."
 
Vol 7, No 4 (2011) LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE Abstract  similar documents
O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov
"... anticoagulant therapy with warfarin and fraxiparine in patient with dilated cardiomyopathy, congestive heart ..."
 
Vol 14, No 4 (2018) Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice Abstract  similar documents
N. M. Vorobyeva, O. N. kacheva
"... of anticoagulants in real clinical practice and questions of adherence of patients to anticoagulant therapy ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... patients, including warfarin (39.5%), direct oral anticoagulants (DOAC) (46.5%) and low-molecular weight ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
"... A recently published article [1 ] on the problems of anticoagulant therapy in patients ..."
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... and cohort trials). The use of unreasonably low doses of oral anticoagulants in elderly patients is debated ..."
 
Vol 16, No 1 (2020) Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) Abstract  similar documents
N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva
"... , and have a negative effect on the anticoagulant effect of warfarin. Management of patients receiving ..."
 
Vol 10, No 4 (2014) FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW Abstract  similar documents
S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva
"... Strategies for the management of patients with atrial fibrillation (heart rhythm or heart rate ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... to recommend apixaban for widespread use in patients requiring anticoagulant therapy for optimal prevention ..."
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
"... patients had absolute indications to anticoagulant therapy. At admission 60 (14%) patients received new ..."
 
Vol 15, No 5 (2019) Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko
"... . In addition, they emphasize the role of anticoagulant therapy as a preventing tool for the development ..."
 
Vol 10, No 1 (2014) ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES Abstract  similar documents
J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili
"... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... The choice of anticoagulant therapy in patients with atrial fibrillation (AF) and concomitant ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... Up-to-date European approaches to the management of patients with atrial fibrillation (AF) after ..."
 
Vol 13, No 2 (2017) ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC Abstract  PDF (Eng)  similar documents
E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov
"... Aim. To estimate the rate of oral anticoagulants (OAC) prescription, continuity of anticoagulant ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... Current guidelines for the management of atrial fibrillation (AF) recommend using anticoagulants ..."
 
Vol 14, No 1 (2018) UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME Abstract  similar documents
O. V. Krikunova, R. I. Stryuk
"... Anticoagulant therapy is widely used in all forms of acute coronary syndrome (ACS) to inhibit ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... as predictors of choice of optimal anticoagulant therapy in patients with atrial fibrillation (AF). Material ..."
 
Vol 10, No 6 (2014) THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY Abstract  similar documents
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
"... Despite large number of known risk factors of venous thromboembolism (VTE) in cancer patients ..."
 
Vol 14, No 1 (2018) THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov
"... in patients with atrial fibrillation (AF) receiving anticoagulant therapy with warfarin. Material and methods ..."
 
Vol 12, No 3 (2016) THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE Abstract  PDF (Eng)  similar documents
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko
"... to anticoagulation therapy in these patients. Keywords: new oral anticoagulants, apixaban, pharmacokinetics, atrial ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... Recent data and perspectives of antithrombotic therapy in patients with atrial fibrillation (AF ..."
 
Vol 11, No 6 (2015) The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, N. V. Romanova, Yu. F. Osmolovskaya, S. P. Golitsyn
"... and the prevalence of long-term anticoagulant therapy in this group of patients in our country is limited. The first ..."
 
Vol 13, No 5 (2017) ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT Abstract  similar documents
S. G. Kanorskii
"... anticoagulants, recommended for the treatment of patients with AF with moderate or high risk of stroke. Adherence ..."
 
Vol 13, No 6 (2017) PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS Abstract  similar documents
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin
"... in patients before the start of anticoagulant therapy. Results. No thromboembolic events and major bleedings ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... in patients with CKD of inflammatory and non-inflammatory origin are described. Moreover, with the slowing ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... level of adherence compared to patients without anticoagulants (65.2±19.3% vs 68.5±19.1%; Wald-Wolfowitz ..."
 
Vol 12, No 4 (2016) Renal filtration function in patients with gout Abstract  similar documents
N. N. Kushnarenko, T. A. Medvedeva, A. V. Govorin, M. Yu. Mishko
"... , glomerular filtration rate (GFR) was evaluated by CKD-EPI method. Depending on GFR level, all the patients ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... Background. For prevention of thromboembolic events in patients with non-valvular atrial ..."
 
Vol 14, No 3 (2018) THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE Abstract  similar documents
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... long-term anticoagulant therapy with apixaban in a full dose (5 mg b.i.d.), and the patient’s ..."
 
Vol 12, No 2 (2016) CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, M. A. Efremovtseva
"... and persistent, de novo, and on the background of CKD. Results. CKD was detected in 125 (45%) patients. AKI ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... Indirect anticoagulants effectively prevent thromboembolic complications in patients with high ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... New data and perspectives of antithrombotic therapy are highlighted in patients with atrial ..."
 
Vol 16, No 1 (2020) The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation Abstract  similar documents
A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva
"... Aim. To study the efficacy, safety, and adherence to therapy with new oral anticoagulants ..."
 
Vol 14, No 6 (2018) Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding Abstract  PDF (Eng)  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
"... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..."
 
Vol 14, No 4 (2018) Elderly Patient Management Problems: Antithrombotic Therapy Selection Features. Clinical Case Abstract  similar documents
D. U. Akasheva, E. S. Bulgakova, I. S. Yavelov, A. Yu. Gorshkov, O. M. Drapkina
"... and questions, having no answers in any guidelines. Such a difficult clinical case of elderly patient management ..."
 
Vol 11, No 6 (2015) The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev
"... Aim. To study the incidence of comorbidities and their impact on the prognosis in patients ..."
 
Vol 15, No 1 (2019) Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... ) in 2016. A significant number of patients in this group received anticoagulant therapy with vitamin K ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... Large randomized clinical trials (RCTs) in patients with non-valvular atrial fibrillation (AF ..."
 
Vol 4, No 2 (2008) ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? Abstract  similar documents
A. L. Komarov, E. P. Panchenko
"... Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed ..."
 
Vol 12, No 4 (2016) Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation Abstract  similar documents
S. G. Kanorskii
"... in routine clinical practice in patients with non-valvular atrial fibrillation. In consecutive patients who ..."
 
Vol 15, No 5 (2019) Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov
"... Direct oral anticoagulants (not vitamin K antagonists), unlike standard oral anticoagulants (e ..."
 
Vol 13, No 3 (2017) PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION Abstract  similar documents
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko
"... parameters of new oral anticoagulants. The review presents data from studies investigating the effect of gene ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... Up to date antithrombotic medications applied in patients with atrial fibrillation are discussed ..."
 
Vol 12, No 2 (2016) THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE Abstract  similar documents
S. V. Moiseev
"... New oral anticoagulants that inhibit factor Xa (rivaroxaban, apixaban, edoksaban) or thrombin ..."
 
Vol 15, No 6 (2019) Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation Abstract  similar documents
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..."
 
Vol 11, No 1 (2015) ON THE SELECTION OF DRUGS DOSAGE REGIMEN Abstract  similar documents
E. N. Bochanova
"... factors effecting treatment, including patient’s adherence to therapy, that can lead to the need ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... of oral anticoagulants (ОAC) in patients with atrial fibrillation (AF) in 2015-2017. Material and methods ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial ..."
 
Vol 11, No 2 (2015) CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION Abstract  similar documents
V. N. Shishkova
"... events in patients with comorbidity are evaluated. ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... hospitalization in elderly outpatients. Material and methods. The total of 248 patients aged 60–85 years with CHF ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... Aim. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients ..."
 
Vol 9, No 5 (2013) PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko
"... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..."
 
Vol 9, No 5 (2013) APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA Abstract  similar documents
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev
"... The clinical significance of the patient genetic characteristics in the individual pharmacological ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... warfarin, 15% new oral anticoagulants (NOAC). The majority of patients received antiplatelet agents ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..."
 
Vol 12, No 3 (2016) THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT Abstract  PDF (Eng)  similar documents
S. R. Gilyarevskiy
"... of the treatment strategy in patients with VTE are considered. The role of thrombolytic therapy is highlighted ..."
 
Vol 15, No 6 (2019) Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova
"... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... . The oral anticoagulants (OAC) were recommended to patients at the reference visit (n=97). Inquiry ..."
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..."
 
Vol 13, No 1 (2017) DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT Abstract  similar documents
D. А. Napalkov, A. A. Sokolova, V. V. Fomin
"... patients with minimal comorbidity and a number of other restrictions are included into the RCT ..."
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
"...   favorable profile of drug  interaction in comparison with other new oral anticoagulants (NOAC). The basis ..."
 
Vol 2, No 3 (2006) EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS Abstract  similar documents
A. P. Momot, O. V. Bespalova, E. N. Vorobyova
"... The anticoagulants of indirect action during many years serve drugs of basic prophylaxis ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"... Oral anticoagulant (OAC) therapy is currently gaining special importance due to the significant ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... For prevention of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF ..."
 
Vol 14, No 4 (2018) Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases Abstract  similar documents
O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin
"... The issues of prevention of thromboembolic complications (TE) in the management of patients ..."
 
Vol 6, No 3 (2010) THE SPECIFIC FEATURES OF HEART AND VESSELS REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH LISINOPRIL DURING 6 MONTHS Abstract  similar documents
N. A. Kosheleva, A. P. Rebrov
"... -month combined therapy with lisinopril on the heart and vessels remodeling in patients with ischemic CHF ..."
 
Vol 16, No 1 (2020) Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients Abstract  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin
"... conducted in previous years among patients with acute myocardial infarction showed a decrease ..."
 
Vol 12, No 6 (2016) THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME Abstract  similar documents
E. A. Smirnova, S. S. Yakushin
"... The article discusses the choice of anticoagulant in different patterns of acute coronary syndrome ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... Aim. To study the frequency of oral anticoagulants (ОАС) prescription for patients with atrial ..."
 
Vol 11, No 2 (2015) PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST Abstract  similar documents
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
"... Apixaban is a "new" oral anticoagulant, direct Xa factor inhibitor with a good evidence base ..."
 
Vol 14, No 2 (2018) New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion Abstract  similar documents
A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko
"... cohorts of patients. This current review analyzes epidemiological data of trials and registries about ..."
 
Vol 13, No 5 (2017) THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION Abstract  similar documents
M. V. Kurkina, A. G. Avtandilov, I. A. Krutovcev
"... hypertensive patients (aged 40 to 80 years) with concomitant obesity or diabetes or CKD. Patients were divided ..."
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..."
 
Vol 5, No 3 (2009) ANTICOAGULANTS IN ACUTE CORONARY SYNDROME Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... and apixaban in patients with non-valvular atrial fibrillation (AF) and to assess the impact of the both ..."
 
Vol 13, No 6 (2017) ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY Abstract  similar documents
Yu. А. Bunin, S. V. Miklishanskaya
"... antiarrhythmics and not antiarrhythmic drugs, anticoagulants and non-drug treatments in these patients. Based ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... to patients’ death. The prevention of VTE events suggests the prescription of low molecular weight heparin ..."
 
Vol 13, No 6 (2017) CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE Abstract  similar documents
A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina
"... . The study included 103 patients with ACS without indications for long-term anticoagulant therapy, which ..."
 
Vol 8, No 4 (2012) WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE Abstract  similar documents
E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov
"... Analysis of the current literature data on the use of warfarin in patients with cardioembolic ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... oral anticoagulants (NOACs). Material and methods. Cost-effectiveness analysis was performed using ..."
 
Vol 15, No 5 (2019) Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... and their combinations on the survival of patients with atrial fibrillation (AF) in the REKUR-AF study. Material ..."
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
"... Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... Dabigatran is the new oral anticoagulant that directly inhibits thrombin (factor IIa). In RE-LY ..."
 
Vol 9, No 2 (2013) ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS Abstract  similar documents
O. V. Shatalova, O. N. Smuseva, A. S. Maslakov
"... accounted for by indirect- acting anticoagulating agents — 66.7% (12/18), direct-acting anticoagulants — 22 ..."
 
Vol 15, No 5 (2019) Prediction of the Possibility of Hemorrhagic Syndrome during Combined Antiplatelet Therapy According to the Krasnodar Region Registry Abstract  similar documents
Z. G. Tatarintseva, E. D. Kosmacheva, S. V. Kruchinova, V. A. Akinshina, A. A. Khalafyan
"... of Cardiology (ESC), patients with coexisting AF and ACS should receive dual antiplatelet therapy ..."
 
Vol 13, No 2 (2017) TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 Abstract  similar documents
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko
"... Aim. Assessment of compliance the management of elderly patients (≥75 years) with acute coronary ..."
 
Vol 15, No 1 (2019) Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality? Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... and anticoagulant drugs. Medicine from the very beginning was intended to be personalized, but until recently ..."
 
1 - 100 of 1146 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)